PRIMARY GLAUCOMA TRIPLE PROCEDURE IN PATIENTS WITH PRIMARY OPEN-ANGLEGLAUCOMA - THE EFFECT OF MITOMYCIN-C IN PATIENTS WITH AND WITHOUT PROGNOSTIC FACTORS FOR FILTRATION FAILURE
Dh. Shin et al., PRIMARY GLAUCOMA TRIPLE PROCEDURE IN PATIENTS WITH PRIMARY OPEN-ANGLEGLAUCOMA - THE EFFECT OF MITOMYCIN-C IN PATIENTS WITH AND WITHOUT PROGNOSTIC FACTORS FOR FILTRATION FAILURE, American journal of ophthalmology, 125(3), 1998, pp. 346-352
PURPOSE: To investigate the effect of adjunctive mitomycin C on primar
y glaucoma triple procedure in patients with primary open angle glauco
ma with and without one or more of the prognostic factors for filtrati
on failure of primary glaucoma triple procedure. Those factors include
being of African American race, having a preoperative intraocular pre
ssure of 20 mm Hg or more on maximum tolerated medications, and being
on two or more medications preoperatively. METHODS: Study patients con
sisted of 197 consecutive patients with primary open-angle glaucoma wh
o were randomly assigned to receive either no adjunctive mitomycin C (
101 eyes of 101 patients) or to receive adjunctive subconjunctival mit
omycin C (96 eyes of 96 patients) during the primary glaucoma triple p
rocedure. Kaplan-Meier survival analysis comparisons were made between
respective subgroups with and without prognostic indicators for filtr
ation failures using a relatively stringent set of criteria for filtra
tion success of primary glaucoma triple procedure. RESULTS: There was
no statistically significant (P = .117) difference in filtration succe
ss of primary glaucoma triple procedure between the control and mitomy
cin C groups. Adjunctive mitomycin C significantly (P < .05) improved
the filtration outcome of the primary glaucoma triple procedure in the
subgroups with each of the three prognostic factors for filtration fa
ilure of primary glaucoma triple procedure. On the other hand, in the
subgroups without the prognostic factors, adjunctive mitomycin C did n
ot significantly (P > .05) change the filtration outcome of the primar
y glaucoma triple procedure. CONCLUSION: These findings establish the
basis for selective use of mitomycin C in patients with primary open-a
ngle glaucoma undergoing primary glaucoma triple procedure. (C) 1998 b
y Elsevier Science Inc. All rights reserved.